A carregar...
Biomarker Development in the Context of Urologic Cancers
The FDA has called for the use of analytically validated biomarkers that have strong evidence of being fit for purpose to identify patients likely to respond and to evaluate the patient response to a therapy, potential toxicity, and drug resistance. This article discusses development and application...
Na minha lista:
| Publicado no: | Urol Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4521394/ https://ncbi.nlm.nih.gov/pubmed/25746942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2015.01.007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|